MedImmune LLC | MedPath

FDA Approves First Self-Administered Flu Vaccine, FluMist, for At-Home Use

8 months ago

• The FDA has approved FluMist, a nasal spray flu vaccine, for self-administration, marking the first flu vaccine that can be administered at home. • FluMist is approved for individuals aged 2 to 49 and will be available through an online pharmacy with a prescription, starting next flu season. • The approval is based on studies showing that adults can safely and effectively administer the vaccine themselves or to children with proper instructions. • This new option aims to improve convenience, flexibility, and accessibility to seasonal influenza vaccination, potentially increasing vaccination rates.